Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30-Reference-Cited by-同舟云学术

Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30

Published:2024 Issue:1.2 Volume:71 Page:82-91
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Arahori Hiromi¹,Kondo Kazuya¹,Imai Yoshie²,Bando Takae³,Inoue Hiroaki⁴,Sasa Soichiro⁴,Takizawa Hiromitsu⁴

Affiliation:

1. Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

2. Department of Oncology Nursing, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

3. Department of Medical Treatment Recovery Nursing, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

4. Department of Thoracic, Endocrine Surgery and Oncology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/71/1.2/71_82/_pdf

Reference43 articles.

1. 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A : Global cancer statistics 2018 : GLOBOCAN esti mates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68 : 394-424, 2018

2. 2. Cancer Statics in Japan National Cancer Center Web site. https://ganjoho.jp/reg_stat/index.html. Accessed April 24, 2022

3. 3. Cancer Stat Facts : Female Breast Cancer. National Cancer Institute. Web site. https://Seer. cancer gov/statfacts/html/ breast/html. Accessed April 24, 2022

4. 4. Waks AG, Winer EP : Breast cancer treatment a review. JAMA 321 : 288-300, 2019

5. 5. Nyrop KA, Deal AM, Shachar SS, Basch E, Bryce BR, Seul KC, Jordan TL, William AW, Carey KA, Lisa AC, Elizabeth CD, Trevor AJ, Katherine ER, Gretchen GK, Meghan SK, Raquel ER, Joellen CS, Hyman BM : Patient-reported toxicities during chemotherapy regimens in current clinical practice for early breast cancer. The Oncologist 24 : 762-771, 2019